763611007: Emicizumab (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Hematologic agent (substance)\Hemostatic agent (substance)\Emicizumab
\Drug or medicament (substance)\Monoclonal antibody\Bispecific monoclonal antibody (substance)\Emicizumab

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Bispecific monoclonal antibody (substance)\Emicizumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Bispecific monoclonal antibody (substance)\Emicizumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3643017010 Emicizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3643018017 Emicizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1261311000172113 émicizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)
1246971000172117 emicizumab nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Emicizumab	Is a	Monoclonal antibody	false	Inferred relationship	Some
Emicizumab	Is a	Bispecific monoclonal antibody (substance)	true	Inferred relationship	Some
Emicizumab	Is a	Hemostatic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing emicizumab (medicinal product)	Has active ingredient	True	Emicizumab	Inferred relationship	Some	1
Emicizumab-containing product in parenteral dose form	Has active ingredient	True	Emicizumab	Inferred relationship	Some	1
Emicizumab only product	Has active ingredient	True	Emicizumab	Inferred relationship	Some	1
Product containing only emicizumab in parenteral dose form (medicinal product form)	Has active ingredient	True	Emicizumab	Inferred relationship	Some	1
Product containing precisely emicizumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Emicizumab	Inferred relationship	Some	1
Product containing precisely emicizumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Emicizumab	Inferred relationship	Some	1
Emicizumab 150 mg/mL solution for injection	Has precise active ingredient	True	Emicizumab	Inferred relationship	Some	1
Emicizumab 150 mg/mL solution for injection	Has basis of strength substance (attribute)	True	Emicizumab	Inferred relationship	Some	1

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug